News for Healthier Living

Scientists Uncover Why Some Patients with Rare Leukemia May Not Benefit From Approved Targeted Therapy

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

July 7, 2026


July 8 2026

July 7 2026

July 6 2026

July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026